TCL Archive NCI Disappointed Over Response To Survey Leads; CRAG Proposals Inadequate, More Will Be Sought August 6, 1976
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive In Brief: Cancer Control To Push Environmental Research Occupational Hazards; Bailer to Journal Post May 24, 1974
TCL Archive NCI Bypass Budget Justifies An Extra $900 Million In FY1992; Cancer costs Estimate At $80B A Year January 11, 1991
